Therapeutic Areas · Public Health
Public health programs advance population health through implementation science, surveillance, operational research and systems strengthening.
Overview
Public health programs advance population health through implementation science, surveillance, operational research and systems strengthening.
Guosa Life Sciences partners with governments, donors and multilateral organizations to deliver measurable public health outcomes.
Areas of Expertise
Specialized Capabilities
Why GLS
Our integrated enterprise combines scientific depth, operational excellence and collaborative partnerships to support development across diverse and demanding research environments.
The capability
We support public health research and implementation science: cluster randomized trials, stepped-wedge designs, surveillance studies, health systems research and community-based programs delivered with governments, ministries and multilateral partners.
These studies are conducted in systems rather than in clinics, which changes what delivery means. The unit of intervention is often a facility, district or community, the outcome is measured at population level, and success depends on the cooperation of people who are not study staff.
Regulatory considerations
Cluster and stepped-wedge designs raise consent questions that individual-level trials do not. Where the intervention is delivered at facility or community level, individual consent may be infeasible or inappropriate for the intervention itself while remaining necessary for data collection. Ethics committees expect this distinction to be reasoned explicitly, with gatekeeper permissions documented and community engagement evidenced rather than asserted.
Where research is conducted in low-resource settings, CIOMS guidance shapes what committees will accept on compensation, undue inducement, ancillary care obligations and post-trial access. These are design decisions with cost implications, not consent form wording, and they should be settled before submission because they are among the most common causes of ethics committee revision requests.
How an engagement runs
Unit of randomization, consent architecture, gatekeeper permissions and community engagement plan defined at protocol stage.
Ethics and regulatory approvals, community entry, and training of facility and community-level staff.
Implementation monitored with fidelity assessment, data collection at the specified level, and continuing community engagement.
Analysis accounting for clustering, with implementation findings reported alongside outcomes.
What you receive
A documented consent architecture with gatekeeper permissions. A community engagement record. Fidelity assessment against the implementation plan. Analysis accounting for clustering.
Evidence and context
Our operating assumptions are published rather than asserted. The Future of Clinical Trials in Africa sets out why study performance is increasingly determined by ecosystem maturity rather than site selection, and The Untapped Advantage makes the case that institutions, not regions, are the right unit of qualification. Both are available in full, with executive briefs for readers who want the argument in a shorter form.
Other Therapeutic Areas
Preventive and therapeutic vaccines, pandemic preparedness.
ExploreEarly-phase through global Phase III.
ExploreComplex endpoints and assessment.
ExploreMedical and aesthetic dermatology.
ExploreMedical and aesthetic dermatology.
ExploreAsthma, COPD and acute infection.
ExploreMaternal and reproductive health.
ExploreCardiovascular, diabetes and metabolic.
ExploreSmall, dispersed populations.
ExploreDevice and diagnostic studies.
ExploreDiscuss your public health program with our multidisciplinary team.